Bavarian Nordic Delays MPOX Orders for U.S. Government

Bavarian Nordic A/S has announced that it will be postponing certain existing MPOX orders destined for the U.S. government from 2024 to 2025. This decision impacts the timeline for delivery and possibly the strategic plans of the U.S. healthcare sector.

Bavarian Nordic A/S has announced a postponement of certain existing MPOX orders to the U.S. government. Originally slated for 2024, these orders will now be delivered in 2025, a company spokesperson revealed.

The delay may have implications on the U.S. government's healthcare plans and delivery timelines.

Further coverage on the company's activities and strategies is anticipated as the new timelines approach.

(With inputs from agencies.)